{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 1217500000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1320000000.0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1854300000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DuefromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 369800000.0
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 1171800000.0
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 786100000.0
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 6719500000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 821900000.0
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3438300000.0
            },
            {
                "label": "Operating lease assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 414500000.0
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 2988100000.0
            },
            {
                "label": "Summary of roll forward of the changes in goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5763100000.0
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 1286300000.0
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2423000000.0
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 23854700000.0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 143100000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 430400000.0
            },
            {
                "label": "Accrued expense and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2592300000.0
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3165800000.0
            },
            {
                "label": "Notes payable",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 7267200000.0
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 966700000.0
            },
            {
                "label": "Long-term operating lease liabilities",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 380000000.0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1411800000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 13191500000.0
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -174300000.0
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 13833500000.0
            },
            {
                "label": "Repurchase of common stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000.0
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 10682200000.0
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -19000000.0
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 10663200000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 23854700000.0
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 404600000.0
            },
            {
                "label": "Depreciation, amortization and impairments",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 146900000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Share-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 70000000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 33800000.0
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -15000000.0
            },
            {
                "label": "(Gain) loss on strategic investments",
                "concept": "IncreaseDecreaseInEquitySecuritiesFvNi",
                "unit": "usd",
                "value": -437600000.0
            },
            {
                "label": "Our share of Samsung Bioepis gains (losses)",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -18200000.0
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -71700000.0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -37200000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": -43800000.0
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 112500000.0
            },
            {
                "label": "Accrued expense and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -283600000.0
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 64800000.0
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 80900000.0
            },
            {
                "label": "Net cash flow provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 769000000.0
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 819200000.0
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 913300000.0
            },
            {
                "label": "Proceeds from divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 28100000.0
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 92600000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from sales of strategic investments",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
                "unit": "usd",
                "value": 91200000.0
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": -2700000.0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -64700000.0
            },
            {
                "label": "Purchases of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 600000000.0
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 27100000.0
            },
            {
                "label": "Repayments of borrowings and premiums paid on debt exchange",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 169300000.0
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 11400000.0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -785000000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -80700000.0
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -33000000.0
            }
        ],
        "ic": [
            {
                "label": "Total revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 2694000000.0
            },
            {
                "label": "Cost of sales, excluding amortization and impairment of acquired intangible assets",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 478100000.0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 514200000.00000006
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 595000000.0
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "biib:AmortizationAndImpairmentOfAcquiredIntangibleAssets",
                "unit": "usd",
                "value": 98100000.0
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:Collaborationprofitlosssharing",
                "unit": "usd",
                "value": 68500000.0
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 33800000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total cost and expense",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 1720100000.0
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 973900000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -506900000.0
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 467000000.0
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 44200000.0
            },
            {
                "label": "Equity in (income) loss of investee, net of tax",
                "concept": "biib:IncomeLossFromEquityMethodInvestmentsNetOfTax",
                "unit": "usd",
                "value": -18200000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 404600000.0
            },
            {
                "label": "Net\u00a0income (loss) attributable to noncontrolling interests, net\u00a0of\u00a0tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -5600000.0
            },
            {
                "label": "Net\u00a0income (loss) attributable to noncontrolling interests, net\u00a0of\u00a0tax",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 410200000.0
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 2.7
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 2.69
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 151900000.0
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 152300000.0
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -800000.0
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": 149600000.0
            },
            {
                "label": "Gains (losses) on net investment hedges",
                "concept": "TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 22400000.0
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": -2000000.0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -48500000.0
            },
            {
                "label": "Other comprehensive income:",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 124700000.0
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 534900000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -4900000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 530000000.0
            }
        ]
    }
}